Up-regulation of tumour necrosis factor-alpha receptors on monocytes by desferrioxamine

Clin Exp Immunol. 1992 Mar;87(3):499-503. doi: 10.1111/j.1365-2249.1992.tb03026.x.

Abstract

The effect of endogenously generated reactive oxygen metabolites on the interaction of human blood monocytes with tumour necrosis factor-alpha (TNF-alpha) was investigated. Pre-exposure of unactivated human blood monocytes to dimethylthiourea, a scavenger of hydroxyl radical (OH.), or to desferrioxamine (DFX), an iron chelator preventing the synthesis of OH., enhanced the specific binding of 125I-TNF-alpha to its receptors. Scavengers of superoxide anion or hydrogen peroxide were without effect. DFX-induced up-regulation of 125I-TNF-alpha binding depended on the concentration of the drug (1-5 mM) and on the duration of the treatment (1-18 h). It was not due to a reduction of receptor occupancy by endogenously generated TNF-alpha. Scatchard analysis of binding data revealed that DFX caused an approximately two-fold increase in the number of type II TNF-alpha receptors, with no change in their affinity. This up-regulation, that did not require synthesis of new proteins, was associated with a decrease in the internalization rate of TNF-alpha receptors, the half-life of which was doubled. Conversely, these findings suggest that OH. generation by monocytes may have a physiological role in reducing the activity of membrane-associated TNF-alpha receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding, Competitive
  • Deferoxamine / pharmacology*
  • Humans
  • Monocytes / drug effects*
  • Receptors, Cell Surface / metabolism*
  • Receptors, Tumor Necrosis Factor
  • Thiourea / analogs & derivatives
  • Thiourea / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation / drug effects*

Substances

  • Receptors, Cell Surface
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • 1,3-dimethylthiourea
  • Thiourea
  • Deferoxamine